JP2006514030A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514030A5
JP2006514030A5 JP2004561607A JP2004561607A JP2006514030A5 JP 2006514030 A5 JP2006514030 A5 JP 2006514030A5 JP 2004561607 A JP2004561607 A JP 2004561607A JP 2004561607 A JP2004561607 A JP 2004561607A JP 2006514030 A5 JP2006514030 A5 JP 2006514030A5
Authority
JP
Japan
Prior art keywords
gms
added
stirred
dissolved
reaction mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004561607A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514030A (ja
JP5259048B2 (ja
Filing date
Publication date
Priority claimed from GBGB0229583.0A external-priority patent/GB0229583D0/en
Application filed filed Critical
Publication of JP2006514030A publication Critical patent/JP2006514030A/ja
Publication of JP2006514030A5 publication Critical patent/JP2006514030A5/ja
Application granted granted Critical
Publication of JP5259048B2 publication Critical patent/JP5259048B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004561607A 2002-12-19 2003-12-10 デュロキセチン（ｄｕｌｏｘｅｔｉｎｅ）を調製するための方法およびその中で使用するための中間体 Expired - Fee Related JP5259048B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0229583.0 2002-12-19
GBGB0229583.0A GB0229583D0 (en) 2002-12-19 2002-12-19 A process for preparing duloxetine and intermediates for use therein
PCT/GB2003/005357 WO2004056795A1 (en) 2002-12-19 2003-12-10 A process for preparing duloxetine and intermediates for use therein

Publications (3)

Publication Number Publication Date
JP2006514030A JP2006514030A (ja) 2006-04-27
JP2006514030A5 true JP2006514030A5 (https=) 2007-02-01
JP5259048B2 JP5259048B2 (ja) 2013-08-07

Family

ID=9949985

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004561607A Expired - Fee Related JP5259048B2 (ja) 2002-12-19 2003-12-10 デュロキセチン（ｄｕｌｏｘｅｔｉｎｅ）を調製するための方法およびその中で使用するための中間体

Country Status (24)

Country Link
US (1) US7645890B2 (https=)
EP (2) EP1587801B1 (https=)
JP (1) JP5259048B2 (https=)
KR (1) KR100926723B1 (https=)
CN (2) CN101125848B (https=)
AT (1) ATE353081T1 (https=)
AU (2) AU2003292396B2 (https=)
BR (1) BR0316902A (https=)
CA (1) CA2510750A1 (https=)
DE (1) DE60311599T2 (https=)
ES (1) ES2279971T3 (https=)
GB (1) GB0229583D0 (https=)
HR (1) HRP20050657A2 (https=)
IL (1) IL169232A (https=)
IS (1) IS7915A (https=)
MA (1) MA27706A1 (https=)
MX (1) MXPA05006659A (https=)
NZ (2) NZ569874A (https=)
PL (1) PL377380A1 (https=)
PT (1) PT1587801E (https=)
RU (1) RU2351594C2 (https=)
TN (1) TNSN05167A1 (https=)
WO (1) WO2004056795A1 (https=)
ZA (1) ZA200505656B (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7550605B2 (en) * 2004-08-05 2009-06-23 Sun Pharmaceutical Industries Ltd. Process for preparation of an anitdepressant compound
CZ297560B6 (cs) 2004-10-26 2007-02-07 Zentiva, A. S. Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu (duloxetinu)
TWI306858B (en) * 2004-12-23 2009-03-01 Teva Pharma Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof
EP1776049A2 (en) * 2005-01-27 2007-04-25 Teva Pharmaceutical Industries Ltd. Duloxetine hcl polymorphs
WO2006096809A1 (en) 2005-03-08 2006-09-14 Teva Pharmaceutical Industries Ltd. Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate and the preparation thereof
TW200639162A (en) * 2005-03-14 2006-11-16 Teva Pharma Pure duloxetine hydrochloride
US8093408B2 (en) * 2005-06-21 2012-01-10 The Company Wockhardt Antidepressant oral pharmaceutical compositions
US8153824B2 (en) * 2005-06-22 2012-04-10 The Wockhardt Company Antidepressant oral liquid compositions
WO2007038253A2 (en) * 2005-09-22 2007-04-05 Teva Pharmaceutical Industries Ltd. Dnt-maleate and methods of preparation thereof
EP1863782A1 (en) * 2005-12-05 2007-12-12 Teva Pharmaceutical Industries Ltd. 2-(n-methyl-propanamine)-3-(2-naphtol) thiophene, an imputity of duloxetine hydrochloride
EP1971593A2 (en) * 2005-12-12 2008-09-24 Medichem, S.A. Improved synthesis and preparations of duloxetine salts
CZ299270B6 (cs) * 2006-01-04 2008-06-04 Zentiva, A. S. Zpusob výroby hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu
EP1976844A4 (en) * 2006-01-06 2010-11-03 Msn Lab Ltd IMPROVED METHOD FOR PURE DULOXETIN HYDROCHLORIDE
US7538232B2 (en) 2006-01-19 2009-05-26 Eli Lilly And Company Process for the asymmetric synthesis of duloxetine
CA2640212A1 (en) * 2006-02-13 2007-08-23 Teva Pharmaceutical Industries Ltd. A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate
HU228458B1 (en) * 2006-03-13 2013-03-28 Egis Gyogyszergyar Nyrt Duloxetine salts for producing pharmaceutical compositions
SI1857451T1 (sl) 2006-05-05 2010-11-30 Fidia Farmaceutici Postopek priprave intermediata ki je uporaben zaasimetrično sintezo duloksetina
US20080027128A1 (en) * 2006-05-23 2008-01-31 Santiago Ini Duloxetine HCL polymorphs
EP2044049A2 (en) 2006-07-03 2009-04-08 Ranbaxy Laboratories Limited Process for the preparation of enantiomerically pure salts of n-methyl- 3 -( 1-naph-thaleneoxy)- 3 - (-2-thienyl) propanamine
CZ300116B6 (cs) * 2006-12-05 2009-02-11 Zentiva, A. S. Zpusob cištení hydrochloridu (S)-N-methyl-3-(1-naftyloxy)-3-(2-thienyl)propylaminu
HU227730B1 (en) 2006-12-22 2012-01-30 Richter Gedeon Nyrt Process for the preparation of duloxetine and for their the intermediates
CN101657438A (zh) 2006-12-22 2010-02-24 斯索恩有限公司 制备度洛西汀和相关化合物的方法
US8269023B2 (en) 2007-03-05 2012-09-18 Lupin Ltd. Process for preparation of duloxetine hydrochloride
WO2009019719A2 (en) * 2007-08-09 2009-02-12 Ind-Swift Laboratories Limited Process for the preparation of 3-aryloxy-3-arylpropanamines
WO2009130708A2 (en) * 2008-04-22 2009-10-29 Shodhana Laboratories Limited Preparation of duloxetine and its salts
WO2010025287A2 (en) 2008-08-27 2010-03-04 Codexis, Inc. Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
EP2329013B1 (en) 2008-08-27 2015-10-28 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
WO2011033366A2 (en) 2009-09-16 2011-03-24 Jubilant Life Sciences Limited Process for the preparation of duloxetine hydrochloride and its precursors
CN103360365A (zh) * 2012-04-06 2013-10-23 李晓红 一种抗抑郁症药物原料药盐酸度洛西汀的制备新工艺
CN104230882B (zh) * 2014-08-29 2017-03-08 宁波美诺华药业股份有限公司 一种度洛西汀盐酸盐杂质的制备方法
CN104829587B (zh) * 2015-05-08 2017-07-21 上海万巷制药有限公司 盐酸度洛西汀的制备
CN107382958B (zh) * 2017-07-05 2021-11-09 浙江华海药业股份有限公司 一种度洛西汀中间体的结晶方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH578532A5 (https=) * 1971-08-03 1976-08-13 Cassella Farbwerke Mainkur Ag
PL233786A1 (https=) 1980-11-14 1982-05-24 Lilly Co Eli
US4777291A (en) * 1985-02-27 1988-10-11 Eli Lilly And Company Racemization process
JPS62286959A (ja) * 1986-06-05 1987-12-12 Seitetsu Kagaku Co Ltd 光学活性シアノカルニチン塩の製造方法
US4956388A (en) * 1986-12-22 1990-09-11 Eli Lilly And Company 3-aryloxy-3-substituted propanamines
KR880007433A (ko) * 1986-12-22 1988-08-27 메리 앤 터커 3-아릴옥시-3-치환된 프로판아민
CA2042346A1 (en) * 1990-05-17 1991-11-18 Michael Alexander Staszak Chiral synthesis of 1-aryl-3-aminopropan-1-ols
JPH09176157A (ja) * 1992-12-09 1997-07-08 Takeda Chem Ind Ltd 光学活性アミノクマラン誘導体
US5362886A (en) * 1993-10-12 1994-11-08 Eli Lilly And Company Asymmetric synthesis
US6458955B1 (en) 1994-12-16 2002-10-01 Uop Llc Process for preparation of pharmaceutically desired enantiomers
US6162949A (en) 1994-12-16 2000-12-19 Uop Llc Process for preparation of the pharmaceutically desired (S)-oxetine enantiomers
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders
HUP0101901A3 (en) * 1998-05-22 2002-06-28 Lilly Co Eli Pharmaceutical composition for combined therapeutic treatment of refractory depression and combined treating process
CA2350531A1 (en) * 1998-11-13 2000-05-25 Smriti Iyengar Method for treating pain
ATE309196T1 (de) * 1999-04-09 2005-11-15 Lilly Co Eli Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte
WO2001044166A1 (en) * 1999-12-17 2001-06-21 Ranbaxy Laboratories Limited Process for the preparation of fluoxetine hydrochloride
WO2003062219A1 (en) 2002-01-24 2003-07-31 Eli Lilly And Company Process for preparing an intermediate useful for the asymmetric synthesis of duloxetine

Similar Documents

Publication Publication Date Title
JP2006514030A5 (https=)
CA2393190A1 (en) Substituted oxazoles and thiazoles derivatives as hppar alpha activators
JP2012526842A5 (https=)
US11098071B2 (en) GPR84 receptor antagonist and use thereof
JPH0153862B2 (https=)
CA2760384A1 (en) Process for the preparation of [4-(2-chloro-4-methoxy-5-methylphenyl)-5-methyl-thiazolo-2-yl]-[2-cyclopropyl-1-(3-fluoro-4-methylphenyl)-ethyl]-amine
CN1260782A (zh) 制备用作环氧酶－2抑制剂的2－芳基－3－芳基－5－卤代吡啶的方法
JP2005530809A5 (https=)
US8207356B2 (en) Method for the preparation of (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
US20110034690A1 (en) Process for the preparation of pure prulifloxacin
JP3712619B2 (ja) カテコールヒドラゾン誘導体、製造方法及びこれを含む医薬組成物
EP2089375B1 (en) A method of purification of (s)-n-methyl-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride (duloxetine)
TW440557B (en) Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
KR19990001101A (ko) 캐테콜 아미노산 유도체, 이의 제조방법 및 그를 함유한 약제 조성물
JP2011001309A (ja) オキシインドール誘導体及び神経細胞死抑制剤
JP2005519117A5 (https=)
CN1105996A (zh) 咪唑并吡啶类衍生物的制备方法
US7425639B2 (en) Process
JP2002322162A (ja) チアゾリジン誘導体
US10131674B2 (en) Process for preparing Substituted Indole Compounds
WO2012066561A1 (en) An improved process for the preparation of 2-arylthiazole derivatives
US5250551A (en) New (hetero)aryl substituted diazole derivatives, the method of preparing them and application thereof in therapeutics
JPH1160552A (ja) チオベンズアミド誘導体の製造方法
JP2005536557A5 (https=)
EP2226321A3 (en) Process for producing thiazolidinediones and intermediates thereof